1. Z. Jin, J.-Y. Liu, R. Feng, L. Ji, Z.-L. Jin, H.-B. Li, Drug treatment of coronavirus disease 2019 (COVID-19) in China. Eur. J. Pharmacol.Pharmacol. 883, 1–7 (2020)
2. Q. Zhang, Y. Wei, M. Chen, Q. Wan, X. Chen, Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. J. Diabetes Complicat. 34(10), 1–5 (2020)
3. P. Melin, J. Monica, D. Sánchez, O. Castillo, Analysis of spatial spread relationships of coronavirus (COVID-19) pandemic in the world using self organizing maps. Chaos Solitons Fractals 138, 1–7 (2020)
4. D. Reddy, V. Atam, P. Rai, F. Khan, S. Pandey, H. Malhotra, K. Gupta, S. Sonkar, R. Verma, COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: a lesson from Northern India. Clin. Epidemiol. Health 15, 1–6 (2022)
5. L. Zha, T. Sobue, A. Hirayama, T. Takeuchi, K. Tanaka, Y. Katayama, S. Komukai, T. Shimazu, T. Kitamura, COVID-19 epidemiology research group, “Characteristics and outcomes of COVID-19 in reproductive-aged pregnant and nonpregnant women in Osaka, Japan.” Int. J. Infect. Dis. 117, 195–200 (2022)